Company: CYTK
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013167
Chunk: 34

Company: CYTOKINETICS INC
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 34
---
 granted to Mr. Lee that are exercisable within 60 days of February 28, 2025. |

| (11) | Represents (a) 52,826 shares of Common Stock held by Dr. Malik; and (b) 449,298 shares of Common Stock underlying options granted to Dr. Malik that are exercisable within 60 days of February 28, 2025. |

| (12) | Represents (a) 12,031 shares of Common Stock held by Ms. Bhanji; and (b) 70,133 shares of Common Stock underlying options granted to Ms. Bhanji that are exercisable within 60 days of February 28, 2025. |

| (13) | Represents (a) 10,579 shares of Common Stock held by Dr. Harrington; and (b) 60,133 shares of Common Stock underlying options granted to Dr. Harrington that are exercisable within 60 days of February 28, 2025. |

| (14) | Represents (a) 43,595 shares of Common Stock held by Dr. Henderson; (b) 83 shares held by Dr. Henderson’s spouse; and (c) 207,516 shares of Common Stock underlying options granted to Dr. Henderson that are exercisable within 60 days of February 28, 2025. Dr. Henderson disclaims beneficial ownership of the shares of Common Stock held by his spouse. |

| (15) | Represents (a) 20,208 shares of Common Stock held by Dr. Kaye; and (b) 152,513 shares of Common Stock underlying options granted to Dr. Kaye that are exercisable within 60 days of February 28, 2025. |

| 22 |     | Cytokinetics, Inc.|2025 Proxy Statement |

TABLE OF CONTENTS Security Ownership of Certain Beneficial Owners and Management

| (16) | Represents 1,418 shares of Common Stock underlying options granted to Mr. Landry that are exercisable within 60 days of February 28, 2025. |

| (17) | Represents (a) 15,000 shares of Common Stock held by Ms. Parshall; and (b) 37,882 shares of Common Stock underlying options granted to Ms. Parshall that are exercisable within 60 days of February 28, 2025. |

| (18) | Represents (a) 19,171 shares of